益气活血方治疗巨大破裂型腰椎间盘突出症的中长期疗效:一项倾向性评分匹配观察研究OA
A Propensity Score-Matched Observational Study on the Medium-to-Long-Term Efficacy of the Yiqi Huoxue Formula in Treating Massive Ruptured Lumbar Disc Herniation
目的:观察益气活血方治疗巨大破裂型腰椎间盘突出症(LDH)的中长期临床疗效.方法:连续收集2017年5月至2022年6月符合纳入标准的130例患者,按治疗方案分为益气活血方联合基础保守治疗组(简称益气活血方组)与单纯基础保守治疗组(简称对照组).采用倾向性评分匹配(PSM)1∶1平衡两组基线资料(包括年龄、性别、突出率、突出物面积、椎管占位百分比及JOA评分、VAS评分、ODI评分等),最终每组纳入48例.比较两组治疗前及治疗后3,6,12个月的VAS评分、ODI评分、JOA评分,以及1年后的影像学参数.结果:匹配后两组患者的基线特征均衡.重复测量方差分析显示,所有患者JOA评分、VAS评分、ODI评分均随时间显著改善(时间主效应P<0.001).益气活血方组JOA评分和VAS评分改善趋势优于对照组(交互作用P<0.001),各随访时间点JOA评分均更高,VAS评分均更低(P<0.001).两组ODI评分均显著改善,但组间改善趋势差异无统计学意义(交互作用P=0.998).治疗12个月后,益气活血方组影像学指标改善优于对照组(P<0.001).治疗期间两组不良反应发生率差异无统计学意义(P>0.05),且均为轻度胃肠道不适,对症处理后缓解.结论:益气活血方治疗巨大破裂型腰椎间盘突出症中长期疗效确切,在改善神经功能、缓解疼痛及促进突出物重吸收方面均优于普通保守治疗,可为巨大破裂型腰椎间盘突出症提供更具优势的中西医结合保守治疗新选择.
Objective:Observation of the medium-to-long-term clinical efficacy of the Yiqi Huoxue formula in treating mas-sive ruptured lumbar disc herniation(LDH).Methods:A total of 130 eligible patients were consecutively enrolled from May 2017 to June 2022.They were divided into two groups based on treatment regimens:the Yiqi Huoxue formula com-bined with basic conservative treatment group(referred to as the Yiqi Huoxue formula group)and the basic conservative treatment alone group(referred to as the control group).Propensity score matching(PSM)was employed to achieve a 1∶1 balance between groups in terms of baseline characteristics(including age,gender,herniation rate,herniation area,percentage of spinal canal involvement,and JO A scores,VAS scores,and ODI scores),resulting in 48 patients per group.Pre-treatment and post-treatment VAS scores,ODI scores,and JO A scores at 3,6,and 12 months,as well as imaging parameters at 1 year,were compared be-tween groups.Results:After matching,baseline characteris-tics were balanced between the two patient groups.Repeated measures ANOVA revealed significant improvements in JOA scores,VAS scores,and ODI scores over time for all patients(main effect of time,P<0.001 for all).The Yiqi Huoxue formula group showed a superior trend in JOA scores and VAS scores improvement compared to the control group(inter-action P<0.001),with consistently higher JOA scores and lower VAS scores at all follow-up time points(all P<0.001).Both groups showed significant improvement in ODI scores,but there was no statistically significant difference in the trend of improvement between groups(interaction P=0.998).After 12 months of treatment,the Yiqi Huoxue formu-la group demonstrated superior improvements in all imaging parameters compared to the control group(all P<0.001).There was no significant difference in the incidence of adverse reactions between the two groups during treatment(P>0.05),with both groups experiencing only mild gastrointestinal discomfort that resolved after symptomatic management.Conclusion:The Yiqi Huoxue formula demonstrates reliable medium-to-long-term efficacy in treating massive ruptured lumbar disc herniation.It significantly outperforms conventional conservative treatment in improving neurological func-tion,alleviating pain,and promoting reabsorption of the herniated material,establishing itself as an effective conservative therapeutic approach for this condition.
龚焱;林顺;王志强;卓航;柴源;许苏梁;戴锋;姜宏;刘锦涛
南京中医药大学附属苏州市中医医院(江苏苏州,215000)南京中医药大学附属苏州市中医医院(江苏苏州,215000)南京中医药大学附属苏州市中医医院(江苏苏州,215000)南京中医药大学附属苏州市中医医院(江苏苏州,215000)南京中医药大学附属苏州市中医医院(江苏苏州,215000)南京中医药大学附属苏州市中医医院(江苏苏州,215000)南京中医药大学附属苏州市中医医院(江苏苏州,215000)南京中医药大学附属苏州市中医医院(江苏苏州,215000)南京中医药大学附属苏州市中医医院(江苏苏州,215000)
医药卫生
益气活血方巨大破裂型腰椎间盘突出症倾向评分匹配保守治疗重吸收
Yiqi Huoxue formulamassive ruptured lumbar disc herniationpropensity score matchingconservative treat-mentresorption
《中国中医骨伤科杂志》 2026 (1)
13-19,7
国家自然科学基金面上项目(82474529)江苏省自然科学基金面上项目(BK20241802)江苏省中医药领军人才培养项目(SLJ0310)江苏省中医药科技发展计划面上项目(MS2022080)
评论